S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Urgent Warning (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Urgent Warning (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Urgent Warning (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Urgent Warning (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
ETR:DRW3

Drägerwerk AG & Co. KGaA - DRW3 Price Target & Analyst Ratings

€40.95
+0.40 (+0.99%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
€40.30
€40.95
50-Day Range
€39.65
€43.90
52-Week Range
€38.20
€53.05
Volume
4,105 shs
Average Volume
33,804 shs
Market Capitalization
$352.17 million
P/E Ratio
N/A
Dividend Yield
0.46%
Price Target
€40.05

Drägerwerk AG & Co. KGaA Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

€40.05
High Prediction€44.10
Average Prediction€40.05
Low Prediction€36.00
TypeCurrent
3/26/22 to 3/26/23
1 Month Ago
2/24/22 to 2/24/23
3 Months Ago
12/26/21 to 12/26/22
1 Year Ago
3/26/21 to 3/26/22
Consensus RatingN/AN/AN/A
Moderate Buy
Strong Buy N/A N/A N/A
0 Strong Buy rating(s)
Buy N/A N/A N/A
2 Buy rating(s)
Hold N/A N/A N/A
2 Hold rating(s)
Sell N/A N/A N/A
0 Sell rating(s)
Consensus Price Target€40.05€39.12€47.43€72.42
Get Drägerwerk AG & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DRW3 and its competitors with MarketBeat's FREE daily newsletter.

DRW3 Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DRW3 Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Drägerwerk AG & Co. KGaA Stock vs. The Competition

TypeDrägerwerk AG & Co. KGaAMedical Companies
Consensus Rating Score
0.00
2.64
Consensus RatingN/ABuy
News Sentiment RatingNeutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/16/2023Warburg Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Christian Ehmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€44.10+4.13%
1/17/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Henrik Paganetty
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€36.00-11.33%
1/11/2022Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Oliver, Reinberg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€55.00+7.32%
11/25/2021Nord/LB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Holger, Fechner
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€72.00+21.21%
7/16/2021Hauck and Aufhaeuser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aliaksandr Halitsa
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€96.50+29.44%
4/20/2021DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy
4/16/2021Independent Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetNeutral€78.00+1.89%
(Data available from 3/26/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












DRW3 Price Target - Frequently Asked Questions

Does Drägerwerk AG & Co. KGaA's stock price have much downside?

According to analysts, Drägerwerk AG & Co. KGaA's stock has a predicted downside of -3.44% based on their 12-month price targets.

What analysts cover Drägerwerk AG & Co. KGaA?

Drägerwerk AG & Co. KGaA has been rated by Jefferies Financial Group, and Warburg Research in the past 90 days.


Stock Ratings Reports and Tools

This page (ETR:DRW3) was last updated on 3/26/2023 by MarketBeat.com Staff